Table 1 Baseline Patients characteristics of the study groups
From: Acute kidney injury in hospitalized patients with COVID-19 (retrospective study)
Parameter | All (n = 86) | AKI (n = 61) | Non-AKI (n = 25) | P value |
|---|---|---|---|---|
Age, years | 58.07 ± 17.9 | 55.28 ± 17.8 | 65.48 ± 16.5 | 0.017* |
Sex (male/female) | 38/48 | 31/30 | 7/18 | 0.044** |
Onset of symptoms | ||||
• Acute | 7 (8.1%) | 5 (8.2%) | 2 (8%) | 0.891** |
• Gradual | 32 (37.2%) | 23 (37.7%) | 9 (36%) | |
• Sudden | 47 (54.7%) | 33 (45.1%) | 14 (56%) | |
Comorbidity | ||||
• IHD | 14 (17.1%) | 14 (23%) | 0 (0%) | 0.010** |
• DM | 22 (26.8%) | 15 (24.6%) | 7 (33.3%) | 0.305** |
• HTN | 36 (41.9%) | 28 (45.9%) | 8 (62%) | 0.047** |
• CKD | 8 (9.3%) | 8 (13.1%) | 0 (0%) | 0.045** |
• Liver disease | 6 (7%) | 5 (8.2%) | 1 (4%) | 0.134** |
• Others | 22 (25.6%) | 17 (27.9%) | 5 (20%) | 0.041** |